UPDATE: New insights reveal that colchicine, a medication primarily used to treat gout, may significantly lower the risk of heart attack and stroke. This urgent finding was shared by Dr. Oscar Duke during an appearance on BBC Morning Live earlier today, November 19, 2025.
Recent research indicates that colchicine can effectively reduce inflammation, a major contributing factor to cardiovascular events. According to Dr. Duke, a comprehensive systematic review analyzed data from 12 studies involving 23,000 participants, predominantly men, revealing life-changing implications for those with existing heart conditions.
Dr. Duke explained, “For every 1,000 people who took colchicine for six months or longer, there was a reduction of nine heart attacks and eight strokes. This is a significant decrease.” He emphasized that while the results are promising, they apply mainly to individuals with pre-existing heart disease.
“This study acts as secondary prevention, aiming to prevent further incidents in those already at risk,” Dr. Duke cautioned, urging people not to self-medicate.
Colchicine works by targeting inflammation, which is often associated with both gout and cardiovascular issues. Currently prescribed at 500 micrograms two to four times daily, doctors typically recommend this medication for short periods. Nevertheless, some patients may be advised to continue treatment longer, contingent on their specific health needs.
As awareness grows about the potential benefits of colchicine, it remains crucial for patients to consult healthcare professionals before making any changes to their treatment plans. The findings spark hope for many, especially those living with heart disease, highlighting the need for ongoing research into innovative treatments.
For further information about colchicine and its uses, visit the NHS website. Stay tuned for updates as this story develops, as it could reshape how we approach the treatment of heart-related conditions.
